BlackRock Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

BlackRock Group’s Portfolio PGNX Stock Details PGNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$243K	Buy
2016 Q3	$161K	Buy
2016 Q2	$102K	Sell
2016 Q1	$106K	Buy
2015 Q4	$95K	Sell
2015 Q3	$91K	Buy
2015 Q2	$91K	Buy